Shionogi

Shionogi & Co.’s experimental COVID-19 treatment Xocova won emergency approval in Japan, becoming the third oral treatment available in the country and the first to be developed locally. Japan’s health ministry authorized the emergency use of the therapy for COVID-19 patients aged 12 years and older after a panel of […]